Editorial
Exploring the feasibility and effectiveness of robotic-assisted pancreaticoduodenectomy with modified Blumgart pancreaticojejunostomy: a look beyond the technology
Abstract
Pancreaticoduodenectomy (PD) is universally recognized as the only chance for cure for patients affected by periampullary cancers, as well as for premalignant cystic pancreatic neoplasms, and neuroendocrine tumors of the pancreatic head.
